{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:15:17Z","timestamp":1772165717283,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T00:00:00Z","timestamp":1615939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Asymptomatic carriage of COVID-19 in pregnant women has been reported and could lead to outbreaks in maternity units. We sought to ascertain the impact of rapid isothernal nucleic acid based testing for COVID-19 in an unselected cohort of pregnant women attending our maternity unit. We also assessed the correlation between community prevalence and asymptomatic carriage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data for the retrospective cohort study were collected from a large UK tertiary maternity unit over a 4-week period using computerised hospital records. Literature searches were performed across multiple repositories. COVID-19 prevalence was extracted from online repositories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nasopharyngeal and oropharyngeal swabs were obtained from 457\/465 (98%) women during the study period. The median turnaround time for results was 5.3\u2009h (interquartile range (IQR) 2.6\u20138.9\u2009h), with 92% of the results returned within 24\u2009h. In our cohort, only one woman tested positive, giving a screen positive rate of 0.22% (1\/457; 95% CI: 0.04\u20131.23%). One woman who tested negative developed a fever postnatally following discharge but was lost to follow-up. From our literature review, we did not find any correlation between asymptomatic carriage in pregnant women and the reported regional prevalence of COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Testing using the SAMBA-II machine was acceptable to the vast majority of pregnant women requiring admission and had a low turnaround time. Asymptomatic carriage is low, but not correlated to community prevalence rates. Screening pregnant women on admission will remain an important component in order to minimise nosocomial infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-021-03653-4","type":"journal-article","created":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T10:02:46Z","timestamp":1615975366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Samba II PCR testing for COVID-19 in pregnant women: a retrospective cohort study and literature review"],"prefix":"10.1186","volume":"21","author":[{"given":"Ruiling","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara Alicia","family":"Pauley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah","family":"Missfelder-Lobos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard John","family":"Haddon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindra Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4662-3882","authenticated-orcid":false,"given":"Hsu Phern","family":"Chong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,17]]},"reference":[{"key":"3653_CR1","unstructured":"WHO. Rolling updates on coronavirus disease (COVID-19). https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/events-as-they-happen. Accessed 1 Aug 2020."},{"key":"3653_CR2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395:497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5.","journal-title":"Lancet (London, England)"},{"key":"3653_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271\u201380.e8. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052.","journal-title":"Cell"},{"key":"3653_CR4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.7326\/M20-0504","volume":"172","author":"SA Lauer","year":"2020","unstructured":"Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020;172:577\u201382. https:\/\/doi.org\/10.7326\/M20-0504.","journal-title":"Ann Intern Med"},{"key":"3653_CR5","doi-asserted-by":"publisher","unstructured":"Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y, et al. Antibody Responses to SARS-CoV-2 in Patients with Novel Coronavirus Disease 2019. Clin Infect Dis. 2020;71:2027\u201334. https:\/\/doi.org\/10.1093\/cid\/ciaa344.","DOI":"10.1093\/cid\/ciaa344"},{"key":"3653_CR6","unstructured":"Mlcochova P, Collier D, Ritchie A, Assennato SM, Hosmillo M, Goel N, et al. Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G spike variant. Cell Reports Medicine. 2020;1."},{"key":"3653_CR7","volume-title":"The role of asymptomatic SARS-CoV-2 infections: rapid living systematic review and meta-analysis","author":"DC Buitrago-Garcia","year":"2020","unstructured":"Buitrago-Garcia DC, Egli-Gany D, Counotte MJ, Hossmann S, Imeri H, Salanti G, et al. The role of asymptomatic SARS-CoV-2 infections: rapid living systematic review and meta-analysis. 2020."},{"key":"3653_CR8","doi-asserted-by":"publisher","unstructured":"Sutton D, Fuchs K, D\u2019Alton M, Goffman D. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery. New England J Med. 2020;382:2163\u20134. https:\/\/doi.org\/10.1056\/nejmc2009316.","DOI":"10.1056\/nejmc2009316"},{"key":"3653_CR9","doi-asserted-by":"publisher","unstructured":"Assennato SM, Ritchie AV, Nadala C, Goel N, Zhang H, Datir R, et al. Performance evaluation of the point-of-care SAMBA II SARS-CoV-2 Test for detection of SARS-CoV-2. medRxiv. 2020. https:\/\/doi.org\/10.1101\/2020.05.24.20100990v3.","DOI":"10.1101\/2020.05.24.20100990v3"},{"key":"3653_CR10","doi-asserted-by":"publisher","unstructured":"Collier DA, Assennato SM, Warne B, Sithole N, Sharrocks K, Ritchie A, et al. Point of care nucleic acid testing for SARS-CoV-2 in hospitalized patients: a clinical validation trial and implementation study. Cell Reports Medicine. 2020;1. https:\/\/doi.org\/10.1016\/j.xcrm.2020.100062.","DOI":"10.1016\/j.xcrm.2020.100062"},{"key":"3653_CR11","unstructured":"Rivett L, Routledge M, Sparkes D, Warne B, Bartholdson J, Cormie C, et al. Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. eLife. 2020; epub ahead of print."},{"key":"3653_CR12","doi-asserted-by":"publisher","unstructured":"Sridhar S, Forrest S, Kean I, Young J, Scott JB, Maes M, et al. A blueprint for the implementation of a validated approach for the detection of SARS-Cov2 in clinical samples in academic facilities. bioRxiv. 2020;:2020.04.14.041319. https:\/\/doi.org\/10.1101\/2020.04.14.041319.","DOI":"10.1101\/2020.04.14.041319"},{"key":"3653_CR13","doi-asserted-by":"publisher","unstructured":"Fassett MJ, Lurvey LD, Yasumura L, Nguyen M, Colli JJ, Volodarskiy M, et al. Universal SARS-Cov-2 screening in women admitted for delivery in a large managed care organization. Am J Perinatol. 2020. https:\/\/doi.org\/10.1055\/s-0040-1714060.","DOI":"10.1055\/s-0040-1714060"},{"key":"3653_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ajog.2020.05.017","volume":"223","author":"L Gagliardi","year":"2020","unstructured":"Gagliardi L, Danieli R, Suriano G, Vaccaro A, Tripodi G, Rusconi F, et al. Universal severe acute respiratory syndrome coronavirus 2 testing of pregnant women admitted for delivery in 2 Italian regions. Am J Obstet Gynecol. 2020;223:291\u20132. https:\/\/doi.org\/10.1016\/j.ajog.2020.05.017.","journal-title":"Am J Obstet Gynecol"},{"key":"3653_CR15","doi-asserted-by":"publisher","unstructured":"Herraiz I, Folgueira D, Villala\u00edn C, Forc\u00e9n L, Delgado R, Galindo A. Universal screening for SARS-CoV-2 before labor admission during Covid-19 pandemic in Madrid. J Perinat Med. 2020. https:\/\/doi.org\/10.1515\/jpm-2020-0236.","DOI":"10.1515\/jpm-2020-0236"},{"key":"3653_CR16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/AOG.0000000000003987","volume":"136","author":"M Naqvi","year":"2020","unstructured":"Naqvi M, Burwick RM, Ozimek JA, Greene NH, Kilpatrick SJ, Wong MS. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) universal testing experience on a Los Angeles labor and delivery unit. Obstet Gynecol. 2020;136:235\u20136. https:\/\/doi.org\/10.1097\/AOG.0000000000003987.","journal-title":"Obstet Gynecol"},{"key":"3653_CR17","doi-asserted-by":"publisher","unstructured":"LaCourse SM, Kachikis A, Blain M, Simmons LE, Mays JA, Pattison AD, et al. Low prevalence of SARS-CoV-2 among pregnant and postpartum patients with universal screening in Seattle, Washington. Clinical Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa675.","DOI":"10.1093\/cid\/ciaa675"},{"key":"3653_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/uog.22099","volume":"56","author":"D Ceulemans","year":"2020","unstructured":"Ceulemans D, Thijs I, Schreurs A, Vercammen J, Lannoo L, Deprest J, et al. Screening for COVID-19 at childbirth: is it effective? Ultrasound Obstetrics Gynecol. 2020;56:113\u20134. https:\/\/doi.org\/10.1002\/uog.22099.","journal-title":"Ultrasound Obstetrics Gynecol"},{"key":"3653_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/AOG.0000000000003983","volume":"136","author":"ES Miller","year":"2020","unstructured":"Miller ES, Grobman WA, Sakowicz A, Rosati J, Peaceman AM. Clinical implications of universal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) testing in pregnancy. Obstet Gynecol. 2020;136:232\u20134. https:\/\/doi.org\/10.1097\/AOG.0000000000003983.","journal-title":"Obstet Gynecol"},{"key":"3653_CR20","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/ijgo.13252","volume":"150","author":"D Ochiai","year":"2020","unstructured":"Ochiai D, Kasuga Y, Iida M, Ikenoue S, Tanaka M. Universal screening for SARS-CoV-2 in asymptomatic obstetric patients in Tokyo, Japan. In J Gynaecol Obstetrics. 2020;150:268\u20139. https:\/\/doi.org\/10.1002\/ijgo.13252.","journal-title":"In J Gynaecol Obstetrics"},{"key":"3653_CR21","doi-asserted-by":"publisher","unstructured":"Campbell KH, Tornatore JM, Lawrence KE, Illuzzi JL, Sussman LS, Lipkind HS, et al. Prevalence of SARS-CoV-2 among patients admitted for childbirth in southern Connecticut. JAMA. 2020;323. https:\/\/doi.org\/10.1001\/jama.2020.8904.","DOI":"10.1001\/jama.2020.8904"},{"key":"3653_CR22","doi-asserted-by":"publisher","unstructured":"Khalil A, Hill R, Ladhani S, Pattisson K, O\u2019Brien P. Severe acute respiratory syndrome coronavirus 2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg. Am J Obstet Gynecol. 2020. https:\/\/doi.org\/10.1016\/j.ajog.2020.05.005.","DOI":"10.1016\/j.ajog.2020.05.005"},{"key":"3653_CR23","doi-asserted-by":"publisher","unstructured":"Yassa M, Yirmibes C, Cavusoglu G, Eksi H, Dogu C, Usta C, et al. Outcomes of universal SARS-CoV-2 testing program in pregnant women admitted to hospital and the adjuvant role of lung ultrasound in screening: a prospective cohort study. J Maternal-Fetal Neonatal Med. 2020:1\u20137. https:\/\/doi.org\/10.1080\/14767058.2020.1798398.","DOI":"10.1080\/14767058.2020.1798398"},{"key":"3653_CR24","doi-asserted-by":"publisher","unstructured":"Prabhu M, Cagino K, Matthews KC, Friedlander RL, Glynn SM, Kubiak JM, et al. Pregnancy and postpartum outcomes in a universally tested population for SARS-CoV-2 in New York City: a prospective cohort study. BJOG. 2020. https:\/\/doi.org\/10.1111\/1471-0528.16403.","DOI":"10.1111\/1471-0528.16403"},{"key":"3653_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ejogrb.2020.05.029","volume":"250","author":"M D\u00f3ria","year":"2020","unstructured":"D\u00f3ria M, Peixinho C, Laranjo M, Mesquita Varej\u00e3o A, Silva PT. Covid-19 during pregnancy: a case series from an universally tested population from the north of Portugal. Eur J Obstet Gynecol Reprod Biol. 2020;250:261\u20132. https:\/\/doi.org\/10.1016\/j.ejogrb.2020.05.029.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"3653_CR26","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1056\/NEJMc2009316","volume":"382","author":"D Sutton","year":"2020","unstructured":"Sutton D, Fuchs K, D\u2019Alton M, Goffman D. Universal screening for SARS-CoV-2 in women admitted for delivery. N Engl J Med. 2020;382:2163\u20134. https:\/\/doi.org\/10.1056\/NEJMc2009316.","journal-title":"N Engl J Med"},{"key":"3653_CR27","doi-asserted-by":"publisher","unstructured":"Buckley A, Bianco A, Stone J. Universal testing of patients and their support persons for severe acute respiratory syndrome coronavirus 2 when presenting for admission to labor and delivery at Mount Sinai Health System. Am J Obstet Gynecol MFM. 2020:100147. https:\/\/doi.org\/10.1016\/J.AJOGMF.2020.100147.","DOI":"10.1016\/J.AJOGMF.2020.100147"},{"key":"3653_CR28","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.ajog.2020.04.024","volume":"223","author":"WS Vintzileos","year":"2020","unstructured":"Vintzileos WS, Muscat J, Hoffmann E, John NS, Vertichio R, Vintzileos AM, et al. Screening all pregnant women admitted to labor and delivery for the virus responsible for coronavirus disease 2019. Am J Obstet Gynecol. 2020;223:284\u20136. https:\/\/doi.org\/10.1016\/j.ajog.2020.04.024.","journal-title":"Am J Obstet Gynecol"},{"key":"3653_CR29","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1055\/s-0040-1712164","volume":"37","author":"V London","year":"2020","unstructured":"London V, McLaren R, Atallah F, Cepeda C, McCalla S, Fisher N, et al. The relationship between status at presentation and outcomes among pregnant women with COVID-19. Am J Perinatol. 2020;37:991\u20134. https:\/\/doi.org\/10.1055\/s-0040-1712164.","journal-title":"Am J Perinatol"},{"key":"3653_CR30","unstructured":"Johns Hopkins University of Medicine Coronavirus Resource Center. https:\/\/coronavirus.jhu.edu\/data."},{"key":"3653_CR31","unstructured":"GOV.UK. Coronavirus (COVID-19) in the UK. https:\/\/coronavirus.data.gov.uk\/cases."},{"key":"3653_CR32","unstructured":"WHO Coronavirus Disease (COVID-19) Dashboard. 2020. https:\/\/covid19.who.int\/."},{"key":"3653_CR33","doi-asserted-by":"publisher","unstructured":"Breslin N, Baptiste C, Gyamfi-Bannerman C, Miller R, Martinez R, Bernstein K, et al. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: two weeks of confirmed presentations to an affiliated pair of New York City hospitals. Am J Obstet Gynecol MFM. 2020:100118. https:\/\/doi.org\/10.1016\/j.ajogmf.2020.100118.","DOI":"10.1016\/j.ajogmf.2020.100118"},{"key":"3653_CR34","doi-asserted-by":"publisher","unstructured":"Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. The BMJ. 2020;370:3320. https:\/\/doi.org\/10.1136\/bmj.m3320.","DOI":"10.1136\/bmj.m3320"},{"key":"3653_CR35","doi-asserted-by":"crossref","unstructured":"Goldenberger D, Leuzinger K, Sogaard KK, Gosert R, Rolo T, Naegele K, et al. Brief validation of the novel GeneXpert Xpress SARS-CoV-2 PCR assay. J Virol Methods. 2020; https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7351036\/.","DOI":"10.1016\/j.jviromet.2020.113925"},{"key":"3653_CR36","unstructured":"Commision CNH. Chinese Clinical Guidance for COVID-19 Pneumonia Diagnosis and Treatment (7th edition) \u6297\u51fb\u65b0\u51a0\u80ba\u708e. http:\/\/kjfy.meetingchina.org\/msite\/news\/show\/cn\/3337.html. Accessed 24 Jun 2020."},{"key":"3653_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ijgo.13188","volume":"150","author":"J Liao","year":"2020","unstructured":"Liao J, He X, Gong Q, Yang L, Zhou C, Li J. Analysis of vaginal delivery outcomes among pregnant women in Wuhan, China during the COVID-19 pandemic. Int J Gynecol Obstet. 2020;150:53\u20137. https:\/\/doi.org\/10.1002\/ijgo.13188.","journal-title":"Int J Gynecol Obstet"},{"key":"3653_CR38","unstructured":"GOV.UK. Statement from the UK Chief Medical Officers on an update to coronavirus symptoms. 2020. https:\/\/www.gov.uk\/government\/news\/statement-from-the-uk-chief-medical-officers-on-an-update-to-coronavirus-symptoms-18-may-2020. Accessed 20 Dec 2020."},{"key":"3653_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s2666-5247(20)30172-5","volume":"5247","author":"M Cevik","year":"2020","unstructured":"Cevik M, Tate M, Lloyd O, Maraolo AE, Schafers J, Ho A. SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis. The Lancet Microbe. 2020;5247:1\u201310. https:\/\/doi.org\/10.1016\/s2666-5247(20)30172-5.","journal-title":"The Lancet Microbe"},{"key":"3653_CR40","unstructured":"RCOG. Principles for the testing and triage of women seeking maternity care in hospital settings, during the COVID-19 pandemic. 2020. https:\/\/www.rcog.org.uk\/globalassets\/documents\/guidelines\/2020-08-10-principles-for-the-testing-and-triage-of-women-seeking-maternity-care-in-hospital-settings-during-the-covid-19-pandemic.pdf. Accessed 15 Aug 2020."}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03653-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12884-021-03653-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-03653-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T10:05:57Z","timestamp":1615975557000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-03653-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,17]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3653"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-03653-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-103715\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,17]]},"assertion":[{"value":"28 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was registered as service evaluation project (ID 3079). All women booked for maternity care at the Rosie Maternity Hospital are asked verbally whether they give their consent for data to be used for research and this is recorded in their computerised hospital records. We can therefore confirm that this is a formally approved method of consenting for use of data in research at the Rosie Maternity Unit. Identifiable data were removed from cases to ensure anonymity. Identifiable data were removed from cases to ensure anonymity. Additionally, in accordance with the United Kingdom National Health Service National Research Ethics Service guidance, neither individual informed consent nor formal research ethics committee review was required, because the study was undertaken by the direct clinical team using information collected in the course of routine care.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors have completed the ICMJE uniform disclosure form at\n                      \n                      and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work. Completed disclosure of interest forms are available to view online as supporting information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}